Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.36%
1,096.72
+3.98
+0.36%
—1,092.741,095.951,103.321,094.72——
SIXC
Communications
SIXC
Communications
SIXC
-0.33%
611.32
-2.04
-0.33%
—613.36613.36613.36609.50——
SIXE
Energy
SIXE
Energy
SIXE
-0.45%
1,171.54
-5.25
-0.45%
—1,176.791,176.521,182.251,166.69——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.45%
1,747.63
-7.91
-0.45%
—1,755.541,759.231,766.301,746.04——
SIXM
Financials
SIXM
Financials
SIXM
-0.58%
631.49
-3.66
-0.58%
—635.15635.20636.89630.09——
SIXR
Staples
SIXR
Staples
SIXR
+0.23%
849.94
+1.93
+0.23%
—848.01852.52855.78849.58——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.09%
218.06
+0.20
+0.09%
—217.86217.86219.52217.86——
SIXT
Technology
SIXT
Technology
SIXT
+3.47%
3,536.03
+118.68
+3.47%
—3,417.353,452.773,536.033,450.39——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.91%
905.07
-8.29
-0.91%
—913.36915.10920.43904.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.86%
1,449.86
-12.52
-0.86%
—1,462.381,461.131,464.531,446.02——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.30%
2,430.47
+7.33
+0.30%
—2,423.142,428.712,448.692,424.63——
DTIL:NASDAQ
Precision BioSciences Inc
$7.69
+2.81%
(+0.21) 1D
$7.70
+0.13% (+0.0100)
After hours
Closed: May 8, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DTIL...
Open
$7.50
High
$7.96
Low
$7.49
Mkt. cap
198.42M
Avg. vol.
234.09K
Volume
182.68K
52-wk high
$8.82
52-wk low
$3.53
EPS
-$3.67
Beta
1.31
Shares outstanding
25.80M
No. of employees
66
News stories
From sources across the web
Profile
Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform. Wikipedia
About Precision BioSciences Inc
CEO-
Employees66
Founded2006
Headquarters-
SectorBiotechnology
Websiteprecisionbiosciences.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
18.00K
13.00K
34.20M
10.84M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11.96M
12.67M
14.46M
13.11M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.93M
8.01M
7.23M
6.80M
Operating expense
21.90M
20.68M
21.70M
19.91M
Total operating expenses
21.90M
20.68M
21.70M
19.91M
Operating income
-21.88M
-20.67M
12.51M
-9.08M
Other non operating income
-1.71M
-1.18M
12.11M
-7.11M
EBT including unusual items
-23.52M
-21.77M
19.25M
-18.44M
EBT excluding unusual items
-23.50M
-21.77M
19.67M
-15.49M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-23.52M
-21.77M
20.13M
-18.44M
Net profit margin
-130,666.67%
-167,476.92%
58.86%
-170.15%
Earnings per share
-2.13
-1.84
1.01
-0.75
Interest and investment income
1.12M
1.03M
773.00K
999.00K
Interest expense
-358.00K
-362.00K
-348.00K
-311.00K
Net interest expenses
758.00K
665.00K
425.00K
688.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.50M
-20.32M
12.85M
-8.78M
Gain or loss from assets sale
25.00K
-3.00K
-465.00K
-4.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer